Gilead Sciences (GILD) Free Cash Flow
Gilead Sciences (GILD) reported free cash flow of $9.5B in fiscal 2025. Since fiscal 2021 ($10.8B), it has declined 12%. The high over this period was $10.8B, in fiscal 2021.
Free: last 5 years
| Fiscal year | FY2007 🔒 | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $10.8B | $8.3B | $7.4B | $10.3B | $9.5B |